Related scientific articles (all)

Expression profiling in: WHO Classification of Tumours of the Breast, (Chapter 1: Invasive Breast Carcinoma: introduction and general features) Chapter book : (IARC, 4th edition, 2012)

Authors : Van de Vijver MJ, Hayes D, Perou C, Sotiriou C, Reis LO
Year : 2012
Journal : Book
Volume : 4th edition
Pages : 29-31

Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design.

Authors : Eiermann W, Bergh J, Cardoso F, Conte P, Crown J, Curtin NJ, Gligorov J, Gusterson B, Joensuu H, Linderholm BK, Martin M, Penault-Llorca F, Pestalozzi BC, Razis E, Sotiriou C, Tjulandin S, Viale G
Year : 2012
Journal : Breast
Volume : 21(1)
Pages : 20-6

Préface, in de Cremoux P. (Ed): Signatures moléculaires des cancers. L’Innovation thérapeutique en cancérologie - Chapter book (John Libey Eurotext, 2012)

Authors : Sotiriou C
Year : 2012
Journal : Book
Volume : 6
Pages : VII-VIII

The biological features and prognosis of breast cancer diagnosed during pregnancy: A case-control study.

Authors : Azim HA, Botteri E, Renne G, Dell orto P, Rotmensz N, Gentilini O, Sangalli C, Pruneri G, Di Nubila B, Locatelli M, Sotiriou C, Piccart-Gebhart M, Goldhirsch A, Viale G, Peccatori F
Year : 2012
Journal : Acta oncol (Stockholm)
Volume : 51(5)
Pages : 653-61

Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement.

Authors : Guiu S, Michiels S, André F, Cortes J, Denkert C, Di Leo A, Hennessy BT, Sorlie T, Sotiriou C, Turner N, van de Vijver M, Viale G, Loi S, Reis-Filho JS
Year : 2012
Journal : Ann Oncol
Volume : 23(12)
Pages : 2997-3006

Minimal residual disease and circulating tumor cells in breast cancer: open questions for research.

Authors : Ignatiadis M, Sotiriou C, Pantel K
Year : 2012
Journal : Recent Results Cancer Res.
Volume : 195
Pages : 3-9

Understanding the biology of triple-negative breast cancer.

Authors : Criscitiello C, Azim HA, Schouten PC, Linn SC, Sotiriou C
Year : 2012
Journal : Ann Oncol
Volume : 23 Suppl 6
Pages : vi13-vi18

A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints.

Authors : Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart-Gebhart M
Year : 2012
Journal : Lancet Oncol
Volume : 13(6)
Pages : e240-8

Largest ever DNA methylation dataset for breast cancer completed.

Authors : Dedeurwaerder S, Desmedt C, Calonne E
Year : 2011
Journal : Expert Rev. Mol. Diagn.
Volume : 11(5)
Pages : 470

Consistent metagenes from cancer expression profiles yield agent specific predictors of chemotherapy response.

Authors : Li Q, Eklund AC, Birkbak NJ, Desmedt C, Haibe-Kains B, Sotiriou C, Symmans WF, Pusztai L, Brunak S, Richardson AL, Szallasi Z
Year : 2011
Journal : BMC Bioinformatics
Volume : 12(null)
Pages : 310

HER2 and TOP2A as predictive markers for anthracycline-containing chemotherapy regimens as adjuvant treatment of breast cancer: a meta-analysis of individual patient data.

Authors : Di Leo A, Desmedt C, Bartlett JM, Piette F, Ejlertsen B, Pritchard KI, Larsimont D, Poole C, Isola J, Earl H, Mouridsen H
Year : 2011
Journal : Lancet Oncol
Volume : 12(12)
Pages : 1134-42

Low residual proliferation after short-term letrozole therapy is an early predictive marker of response in high proliferative ER-positive breast cancer.

Authors : Bedard PL, Singhal SK, Ignatiadis M, Bradbury I, Haibe-Kains B, Desmedt C, Loi S, Evans DB, Michiels S, Dixon JM, Miller WR, Piccart-Gebhart M, Sotiriou C
Year : 2011
Journal : Endocr Relat Cancer
Volume : 18(6)
Pages : 721-30

Multiple-input multiple-output causal strategies for gene selection.

Authors : Bontempi G, Haibe-Kains B, Desmedt C, Sotiriou C, Quackenbush J
Year : 2011
Journal : BMC Bioinformatics
Volume : 12(1)
Pages : 458

DNA methylation profiling reveals a predominant immune component in breast cancers.

Authors : Dedeurwaerder S, Desmedt C, Calonne E, Singhal SK, Haibe-Kains B, Defrance M, Michiels S, Volkmar M, Deplus R, Luciani J, Lallemand F, Larsimont D, Toussaint J, Haussy S, Rothé F, Rouas G, Metzger O, Majjaj S, Saini K, Putmans P, Hames G, van Baren N, Coulie PG, Piccart-Gebhart M, Sotiriou C, Fuks F
Year : 2011
Journal : EMBO Mol Med
Volume : 3(12)
Pages : 726-41

Introduction to Gene Expression Profiling In Breast Cancer in “Breast Surgical techniques and Interdisciplinary Management”, (TEXTBOOK Dirbas FM. & Scott-Conner C.E.H. Editors (Springer, 2011 - 440 pages).

Authors : Dirbas FM, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : -

Outils génomiques pouvant aider au choix thérapeutique des cancers du sein – Analyse in « Cancer du Sein : compte-rendu du 12ème Cours francophone supérieur de cancérologie – (TEXTBOOK : Nice, St-Paul de Vence, Janvier 19-22, 2011 » Namer M., Héry M.

Authors : Ignatiadis M, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : 311-16

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

Authors : Berruti A, Generali D, Kaufmann M, Puztai L, Curigliano G, Aglietta M, Gianni L, Miller WR, Untch M, Sotiriou C, Daidone M, Conte P, Kennedy D, Damia G, Petronini P, Di Cosimo S, Bruzzi P, Dowsett M, Desmedt C, Mansel RE, Olivetti L, Tondini C, Sapino A, Fenaroli P, Tortora G, Thorne H, Bertolini F, Ferrozzi F, Danova M, Tagliabue E, de Azambuja E, Makris A, Tampellini M, Dontu G
Year : 2011
Journal : J. Natl. Cancer Inst. Monographs
Volume : 2011(43)
Pages : 147-51

Multifactorial approach to predicting resistance to anthracyclines.

Authors : Desmedt C, Di Leo A, de Azambuja E, Larsimont D, Haibe-Kains B, Selleslags J, Delaloge S, Duhem C, Kains JP, Carly B, Maerevoet M, Vindevoghel A, Rouas G, Lallemand F, Durbecq V, Cardoso F, Salgado R, Rovere R, Bontempi G, Michiels S, Buyse M, Nogaret JM, Qi Y, Symmans F, Pusztai L
Year : 2011
Journal : J. Clin. Oncol.
Volume : 29(12)
Pages : 1578-86

Proteomic changes associated with breast cancer progression in the MCF10AT model.

Authors : Fumagalli D, Michiels S, Sotiriou C
Year : 2011
Journal : Pharmacogenomics
Volume : 12(1)
Pages : 9-10

Beyond trastuzumab: new treatment options for HER2-positive breast cancer.

Authors : Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Year : 2011
Journal : Breast
Volume : 20 Suppl 3
Pages : S20-7